{"study_desc":{"title_statement":{"idno":"FRESH-PEF68-en","IDno":{"metadata_no":[{"agency":"PEF","code":"68"},{"agency":"FReSH","code":"FRESH-PEF68"}]},"title":"Observationnal study on Postmenopausal woman","alternate_title":"PRESAGE"},"study_authorization":{"agency":[{"name":"CNIL"}]},"authoring_entity":[{"name":"Xavier;HEBUTERNE","firstname":"Xavier","lastname":"HEBUTERNE","type":"investigator","extlink":[{"title":"SIREN","uri":"609849153","role":"organisation id"},{"uri":"06167656X","role":"pi id","title":"IdRef"}],"email":"hebuterne.x@chu-nice.fr","affiliationName":"LILLY FRANCE","PILabo":"Eli Lilly France","isContact":true}],"oth_id":[{"name":""}],"production_statement":{"prod_place":"Epidemiology France Portal (PEF)","producers":[{"name":"LILLY FRANCE","extlink":[{"title":"SIREN","uri":"609849153","role":"sponsor id"}],"role":"sponsor"}],"funding_agencies":[{"name":"LILLY FRANCE","extlink":[{"title":"SIREN","uri":"609849153"}]}]},"distribution_statement":{"contact":[{"name":"Xavier;HEBUTERNE","lastname":"HEBUTERNE","firstname":"Xavier","type":"contact","email":"hebuterne.x@chu-nice.fr","affiliationName":"LILLY FRANCE","contactPointLabo":"","extlink":[{"uri":"609849153","role":"organisation id","title":"SIREN"}]}]},"study_info":{"keywords":[{"keyword":"Postmenopausal women"},{"keyword":"mineral bone density"},{"keyword":"osteoporosis"}],"topics":[{"topic":"Rheumatology","vocab":"health theme","extLink":[{"title":"ESV","uri":"http:\/\/data.europa.eu\/8mn\/euroscivoc\/bfb0bafd-7894-45ba-84fc-ddab5fd6c537"},{"title":"MeSH","uri":"D012219"}]},{"topic":"Osteoporosis","vocab":"cim-11","extLink":[{"uri":"http:\/\/id.who.int\/icd\/entity\/2113001430","title":"CIM-11"}]}],"purpose":"Primary objective: estimate the percentage of osteoporotic patients among postmenopausal patients with a mineral bone density measurement for diagnosis purposes and who can benefit from therapeutic recommendations according to French recommendations. Secondary objectives: factors associated with osteoporosis, characteristics and care for patients","abstract":"","coll_dates":[{"start":"2007-01-01","end":"2008-01-01"}],"nation":[{"name":"France","abbreviation":"fr","extLink":{"vocab":"ISO","vocabURI":"fr"}}],"geog_coverage":"","analysis_unit":"Individuals","universe":"{\"level_sex_clusion_I\":[{\"value\":\"Female\",\"concept\":{\"vocab\":\"MeSH\",\"vocabURI\":\"D005260\"}}],\"level_age_clusion_I\":[{\"value\":\"Middle Aged (45 to 64 years)\",\"concept\":{\"vocab\":\"MeSH\",\"vocabURI\":\"D008875\"}},{\"value\":\"Aged (65 to 79 years)\",\"concept\":{\"vocab\":\"MeSH\",\"vocabURI\":\"D000368\"}},{\"value\":\"Aged, 80 and over (80 years and more)\",\"concept\":{\"vocab\":\"MeSH\",\"vocabURI\":\"D000369\"}}],\"level_type_clusion_I\":\"Patients population\",\"level_type_clusion_other\":\"\",\"clusion_I\":\"Postmenopausal woman, - Patient not treated for osteoporosis for at least one year (HRT, raloxifene, bisphosphonate, teriparatide, strontium ranelate), - Patient coming for a bone densitometry for diagnosis purposes, - Patient able to benefit from a therapeutic recommendation for the treatment of osteoporosis (osteopenic or osteoporotic patient with risk factors of fractures).\",\"clusion_E\":\"\"}","data_kind":"['Clinical data','Paraclinical data (non-biological)','Paraclinical data (non-biological) : Imaging']","quality_statement":{"standards":[{"name":"","committee":"","governance":""}],"other_quality_statement":""}},"study_development":{"development_activity":[{"activity_type":"primary evaluation","activity_description":"Health event\/morbidity"}]},"method":{"data_collection":{"time_method":"One-time cross-sectional study","frequency":"","sampling_procedure":"['{\"concept\":{\"vocabURI\":\"Other\",\"vocab\":\"CESSDA\"},\"value\":\"Other\"}']","sample_frame":{"frame_unit":{"unit_type":"['Through organizations (health services or institutions, schools, businesses, etc.)','Through independent healthcare practitioners']"}},"coll_mode":["{\"concept\":{\"vocabURI\":\"Transcription\",\"vocab\":\"CESSDA\"},\"value\":\"Converting or copying information into a structured record\"}"],"research_instrument":"Access on specific project only","sources":[],"target_sample_size":"[500-1000[ individuals","response_rate":"646"},"method_notes":"Observational Study","study_class":"Completed study","notes":[{"subject":"research type","values":["Observational Study"]}]},"data_access":{"dataset_availability":{"access_place":"","complete":"","status":"{\"value\":\"Restricted access\",\"extLink\":[{\"title\":\"COAR\",\"uri\":\"http:\/\/purl.org\/coar\/access_right\/c_16ec\"}]}","notes":""},"dataset_use":{"restrictions":"","conditions":"","conf_dec":[{"txt":""}],"spec_perm":[{"txt":"","required":""}],"contact":[{"name":""}],"deposit_req":"","cit_req":""}}},"additional":{"versionLang":"en","originLang":"en","autoTranslation":false,"status":"Imported","creationDate":"14-12-2010","lastUpdatedManual":"01-01-2018","isContributorPI":"","contributorName":"Xavier HEBUTERNE","contributorAffiliation":"LILLY FRANCE","addTeamMember":"","obtainedAuthorization":{"otherAuthorizingAgency":[""]},"relatedDocument":[],"regulatoryRequirements":{"conformityDeclaration":""},"fundingAgent":{"fundingAgentType":["Industry"],"otherFundingAgentType":[""]},"sponsor":{"sponsorType":["Industry"],"otherSponsorType":[""]},"governance":{"committee":""},"collaborations":{"networkConsortium":""},"theme":{"complementaryInformation":"","RareDiseases":""},"activeFollowUp":{"isActiveFollowUp":false,"followUpModeOther":""},"interventionalStudy":{"researchPurpose":[],"trialPhase":[],"interventionalStudyModel":"","isClinicalTrial":"","otherResearchPurpose":""},"isInclusionGroups":"","allocation":{"allocationMode":"","allocationUnit":""},"masking":{"maskingType":"","blindedMaskingDetails":[]},"arms":[],"intervention":[],"inclusionGroups":[],"collectionProcess":{"collectionModeDetails":"Data collection notebook","collectionModeOther":""},"dataCollection":{"inclusionStrategyOther":"","samplingModeOther":"","recruitmentSourceOther":"","otherDocumentation":""},"dataCollectionIntegration":{"isDataIntegration":false},"geographicalCoverage":{"geoDetail":"National"},"dataTypes":{"clinicalDataDetails":"Patient diagnosis and condition; History of treatments (SARS-COV-2 vaccine; Eligibility criteria;","biologicalDataDetails":"","isDataInBiobank":false,"biobankContent":[],"biobankContentOther":"","dataTypeOther":""},"variableDictionnary":{"variableDictionnaryAvailable":"","variableDictionnaryLink":""},"dataQuality":{"otherDocumentation":""},"mockSample":{"mockSampleAvailable":"","mockSampleLocation":""},"thirdPartySource":{"otherSourceType":[]},"isHealthTheme":true,"fileDscr":{"fileTxt":{"fileCitation":{"titlStmt":{"IDno":[]}}}}},"schematype":"survey"}